Annual CFI
$363.44 M
+$123.87 M+51.70%
December 31, 2024
Summary
- As of March 12, 2025, AGIO annual cash flow from investing activities is $363.44 million, with the most recent change of +$123.87 million (+51.70%) on December 31, 2024.
- During the last 3 years, AGIO annual CFI has fallen by -$885.34 million (-70.90%).
- AGIO annual CFI is now -70.90% below its all-time high of $1.25 billion, reached on December 31, 2021.
Performance
AGIO Cash From Investing Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly CFI
-$49.16 M
-$299.95 M-119.60%
December 31, 2024
Summary
- As of March 12, 2025, AGIO quarterly cash flow from investing activities is -$49.16 million, with the most recent change of -$299.95 million (-119.60%) on December 31, 2024.
- Over the past year, AGIO quarterly CFI has dropped by -$144.67 million (-151.47%).
- AGIO quarterly CFI is now -102.62% below its all-time high of $1.87 billion, reached on March 31, 2021.
Performance
AGIO Quarterly CFI Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM CFI
$363.44 M
-$144.67 M-28.47%
December 31, 2024
Summary
- As of March 12, 2025, AGIO TTM cash flow from investing activities is $363.44 million, with the most recent change of -$144.67 million (-28.47%) on December 31, 2024.
- Over the past year, AGIO TTM CFI has increased by +$123.87 million (+51.70%).
- AGIO TTM CFI is now -80.27% below its all-time high of $1.84 billion, reached on March 31, 2021.
Performance
AGIO TTM CFI Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Cash From Investing Formula
CFI = Cash Inflows from Investments − Cash Outflows for Investments
AGIO Cash From Investing Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +51.7% | -151.5% | +51.7% |
| 3 y3 years | -70.9% | -151.5% | +51.7% |
| 5 y5 years | +297.5% | -151.5% | +51.7% |
AGIO Cash From Investing Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -70.9% | +51.7% | -119.6% | +47.9% | -70.9% | +155.8% |
| 5 y | 5-year | -70.9% | +379.8% | -102.6% | +83.5% | -80.3% | +155.8% |
| alltime | all time | -70.9% | +209.0% | -102.6% | +83.5% | -80.3% | +155.8% |
Agios Pharmaceuticals Cash From Investing History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2024 | $363.44 M(+51.7%) | -$49.16 M(-119.6%) | $363.44 M(-28.5%) |
| Sep 2024 | - | $250.79 M(+573.4%) | $508.11 M(+71.3%) |
| Jun 2024 | - | $37.24 M(-70.1%) | $296.66 M(-3.2%) |
| Mar 2024 | - | $124.56 M(+30.4%) | $306.54 M(+28.0%) |
| Dec 2023 | $239.57 M(-1.5%) | $95.51 M(+142.8%) | $239.57 M(+5.5%) |
| Sep 2023 | - | $39.34 M(-16.5%) | $227.01 M(-22.2%) |
| Jun 2023 | - | $47.13 M(-18.2%) | $291.74 M(-10.9%) |
| Mar 2023 | - | $57.60 M(-30.6%) | $327.43 M(+34.6%) |
| Dec 2022 | $243.26 M(-80.5%) | $82.95 M(-20.3%) | $243.26 M(+269.2%) |
| Sep 2022 | - | $104.07 M(+25.7%) | $65.89 M(-124.3%) |
| Jun 2022 | - | $82.81 M(-411.6%) | -$270.91 M(-58.4%) |
| Mar 2022 | - | -$26.57 M(-71.9%) | -$651.87 M(-152.2%) |
| Dec 2021 | $1.25 B(+1548.6%) | -$94.42 M(-59.4%) | $1.25 B(-11.7%) |
| Sep 2021 | - | -$232.73 M(-21.9%) | $1.41 B(-7.0%) |
| Jun 2021 | - | -$298.15 M(-115.9%) | $1.52 B(-17.4%) |
| Mar 2021 | - | $1.87 B(+2524.9%) | $1.84 B(+2331.4%) |
| Dec 2020 | $75.75 M(-17.2%) | $71.40 M(-156.6%) | $75.75 M(-142.0%) |
| Sep 2020 | - | -$126.24 M(-662.1%) | -$180.42 M(-788.6%) |
| Jun 2020 | - | $22.46 M(-79.2%) | $26.20 M(-61.6%) |
| Mar 2020 | - | $108.14 M(-158.5%) | $68.22 M(-25.4%) |
| Dec 2019 | $91.44 M(-133.4%) | -$184.77 M(-329.9%) | $91.44 M(-65.3%) |
| Sep 2019 | - | $80.38 M(+24.7%) | $263.41 M(+41.8%) |
| Jun 2019 | - | $64.48 M(-50.9%) | $185.80 M(+641.4%) |
| Mar 2019 | - | $131.35 M(-1125.8%) | $25.06 M(-109.2%) |
| Dec 2018 | -$273.82 M | -$12.80 M(-562.1%) | -$273.82 M(+24.9%) |
| Sep 2018 | - | $2.77 M(-102.9%) | -$219.17 M(+40.9%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Jun 2018 | - | -$96.26 M(-42.5%) | -$155.53 M(-53.6%) |
| Mar 2018 | - | -$167.53 M(-500.3%) | -$334.99 M(+478.5%) |
| Dec 2017 | -$57.91 M(-51.5%) | $41.85 M(-37.0%) | -$57.91 M(-67.3%) |
| Sep 2017 | - | $66.42 M(-124.1%) | -$177.27 M(-42.1%) |
| Jun 2017 | - | -$275.73 M(-351.7%) | -$306.44 M(-6192.1%) |
| Mar 2017 | - | $109.55 M(-241.3%) | $5.03 M(-104.2%) |
| Dec 2016 | -$119.35 M(-193.0%) | -$77.52 M(+23.5%) | -$119.35 M(+471.8%) |
| Sep 2016 | - | -$62.74 M(-275.6%) | -$20.87 M(-129.0%) |
| Jun 2016 | - | $35.74 M(-341.0%) | $72.03 M(+5.2%) |
| Mar 2016 | - | -$14.83 M(-170.8%) | $68.49 M(-46.6%) |
| Dec 2015 | $128.31 M(-138.5%) | $20.96 M(-30.5%) | $128.31 M(-171.3%) |
| Sep 2015 | - | $30.16 M(-6.4%) | -$179.95 M(-20.1%) |
| Jun 2015 | - | $32.21 M(-28.4%) | -$225.21 M(-18.4%) |
| Mar 2015 | - | $44.99 M(-115.7%) | -$276.08 M(-17.2%) |
| Dec 2014 | -$333.34 M(+282.2%) | -$287.30 M(+1802.9%) | -$333.34 M(+401.7%) |
| Sep 2014 | - | -$15.10 M(-19.1%) | -$66.44 M(-49.7%) |
| Jun 2014 | - | -$18.67 M(+52.2%) | -$132.07 M(+27.6%) |
| Mar 2014 | - | -$12.27 M(-39.9%) | -$103.52 M(+18.7%) |
| Dec 2013 | -$87.22 M(-478.5%) | -$20.41 M(-74.7%) | -$87.22 M(+85.7%) |
| Sep 2013 | - | -$80.72 M(-917.1%) | -$46.97 M(-246.6%) |
| Jun 2013 | - | $9.88 M(+144.8%) | $32.03 M(+91.9%) |
| Mar 2013 | - | $4.04 M(-79.7%) | $16.69 M(-27.6%) |
| Dec 2012 | $23.04 M(-203.1%) | $19.84 M(-1252.0%) | $23.04 M(+618.9%) |
| Sep 2012 | - | -$1.72 M(-68.5%) | $3.21 M(-35.0%) |
| Jun 2012 | - | -$5.46 M(-152.6%) | $4.93 M(-52.6%) |
| Mar 2012 | - | $10.39 M | $10.39 M |
| Dec 2011 | -$22.36 M | - | - |
FAQ
- What is Agios Pharmaceuticals annual cash flow from investing activities?
- What is the all time high annual CFI for Agios Pharmaceuticals?
- What is Agios Pharmaceuticals annual CFI year-on-year change?
- What is Agios Pharmaceuticals quarterly cash flow from investing activities?
- What is the all time high quarterly CFI for Agios Pharmaceuticals?
- What is Agios Pharmaceuticals quarterly CFI year-on-year change?
- What is Agios Pharmaceuticals TTM cash flow from investing activities?
- What is the all time high TTM CFI for Agios Pharmaceuticals?
- What is Agios Pharmaceuticals TTM CFI year-on-year change?
What is Agios Pharmaceuticals annual cash flow from investing activities?
The current annual CFI of AGIO is $363.44 M
What is the all time high annual CFI for Agios Pharmaceuticals?
Agios Pharmaceuticals all-time high annual cash flow from investing activities is $1.25 B
What is Agios Pharmaceuticals annual CFI year-on-year change?
Over the past year, AGIO annual cash flow from investing activities has changed by +$123.87 M (+51.70%)
What is Agios Pharmaceuticals quarterly cash flow from investing activities?
The current quarterly CFI of AGIO is -$49.16 M
What is the all time high quarterly CFI for Agios Pharmaceuticals?
Agios Pharmaceuticals all-time high quarterly cash flow from investing activities is $1.87 B
What is Agios Pharmaceuticals quarterly CFI year-on-year change?
Over the past year, AGIO quarterly cash flow from investing activities has changed by -$144.67 M (-151.47%)
What is Agios Pharmaceuticals TTM cash flow from investing activities?
The current TTM CFI of AGIO is $363.44 M
What is the all time high TTM CFI for Agios Pharmaceuticals?
Agios Pharmaceuticals all-time high TTM cash flow from investing activities is $1.84 B
What is Agios Pharmaceuticals TTM CFI year-on-year change?
Over the past year, AGIO TTM cash flow from investing activities has changed by +$123.87 M (+51.70%)